These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 30553157)

  • 21. Structure-activity profiles of novel 6-substituted pyrrolo[2,3-d]pyrimidine thienoyl antifolates with modified amino acids for cellular uptake by folate receptors α and β and the proton-coupled folate transporter.
    Golani LK; George C; Zhao S; Raghavan S; Orr S; Wallace A; Wilson MR; Hou Z; Matherly LH; Gangjee A
    J Med Chem; 2014 Oct; 57(19):8152-66. PubMed ID: 25234128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intermediate states in the binding process of folic acid to folate receptor α: insights by molecular dynamics and metadynamics.
    Della-Longa S; Arcovito A
    J Comput Aided Mol Des; 2015 Jan; 29(1):23-35. PubMed ID: 25323390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of folylpoly-gamma-glutamate synthetase activity is a dominant mechanism of resistance to polyglutamylation-dependent novel antifolates in multiple human leukemia sublines.
    Liani E; Rothem L; Bunni MA; Smith CA; Jansen G; Assaraf YG
    Int J Cancer; 2003 Feb; 103(5):587-99. PubMed ID: 12494465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crystal structures of the closed form of Mycobacterium tuberculosis dihydrofolate reductase in complex with dihydrofolate and antifolates.
    Ribeiro JA; Chavez-Pacheco SM; de Oliveira GS; Silva CDS; Giudice JHP; Libreros-Zúñiga GA; Dias MVB
    Acta Crystallogr D Struct Biol; 2019 Jul; 75(Pt 7):682-693. PubMed ID: 31282477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Folylpoly-γ-glutamate synthetase: A key determinant of folate homeostasis and antifolate resistance in cancer.
    Raz S; Stark M; Assaraf YG
    Drug Resist Updat; 2016 Sep; 28():43-64. PubMed ID: 27620954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FLOG: a system to select 'quasi-flexible' ligands complementary to a receptor of known three-dimensional structure.
    Miller MD; Kearsley SK; Underwood DJ; Sheridan RP
    J Comput Aided Mol Des; 1994 Apr; 8(2):153-74. PubMed ID: 8064332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of potent inhibitors against snake venom metalloproteinase (SVMP) using molecular docking and molecular dynamics studies.
    Chinnasamy S; Chinnasamy S; Nagamani S; Muthusamy K
    J Biomol Struct Dyn; 2015; 33(7):1516-27. PubMed ID: 25192471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Shape-based virtual screening, docking, and molecular dynamics simulations to identify Mtb-ASADH inhibitors.
    Kumar R; Garg P; Bharatam PV
    J Biomol Struct Dyn; 2015; 33(5):1082-93. PubMed ID: 24875451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural investigations into the binding mode of novel neolignans Cmp10 and Cmp19 microtubule stabilizers by in silico molecular docking, molecular dynamics, and binding free energy calculations.
    Tripathi S; Kumar A; Kumar BS; Negi AS; Sharma A
    J Biomol Struct Dyn; 2016 Jun; 34(6):1232-40. PubMed ID: 26212016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural studies on bioactive compounds. 30. Crystal structure and molecular modeling studies on the Pneumocystis carinii dihydrofolate reductase cofactor complex with TAB, a highly selective antifolate.
    Cody V; Chan D; Galitsky N; Rak D; Luft JR; Pangborn W; Queener SF; Laughton CA; Stevens MF
    Biochemistry; 2000 Apr; 39(13):3556-64. PubMed ID: 10736154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis.
    Assaraf YG
    Drug Resist Updat; 2006; 9(4-5):227-46. PubMed ID: 17092765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Binding of the anticancer drug ZD1694 to E. coli thymidylate synthase: assessing specificity and affinity.
    Rutenber EE; Stroud RM
    Structure; 1996 Nov; 4(11):1317-24. PubMed ID: 8939755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Docking and DFT studies on ligand binding to Quercetin 2,3-dioxygenase.
    Malkhasian AY; Howlin BJ
    J Biomol Struct Dyn; 2016 Nov; 34(11):2453-61. PubMed ID: 26599260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anticancer antifolates: current status and future directions.
    McGuire JJ
    Curr Pharm Des; 2003; 9(31):2593-613. PubMed ID: 14529544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular Dynamics for the Optimal Design of Functionalized Nanodevices to Target Folate Receptors on Tumor Cells.
    Donadoni E; Frigerio G; Siani P; Motta S; Vertemara J; De Gioia L; Bonati L; Di Valentin C
    ACS Biomater Sci Eng; 2023 Nov; 9(11):6123-6137. PubMed ID: 37831005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of novel tumor-targeted near-infrared probes with 6-substituted pyrrolo[2,3-d]pyrimidines as targeting ligands.
    Zhang Y; Luo Z; Guo L; Zhang H; Su T; Tan Z; Ren Q; Zhang C; Fu Y; Xing R; Guo R; Shi X; Guo H; Liu Y; Wang L
    Eur J Med Chem; 2023 Dec; 262():115914. PubMed ID: 37925763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure-Based Drug Design Studies Toward the Discovery of Novel Chalcone Derivatives as Potential Epidermal Growth Factor Receptor (EGFR) Inhibitors.
    Al-Anazi M; Al-Najjar BO; Khairuddean M
    Molecules; 2018 Dec; 23(12):. PubMed ID: 30563058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of quinazoline and pyrido[2,3-d]pyrimidine N9-C10 reversed-bridge antifolates in complex with NADP+ and Pneumocystis carinii dihydrofolate reductase.
    Cody V; Galitsky N; Luft JR; Pangborn W; Queener SF; Gangjee A
    Acta Crystallogr D Biol Crystallogr; 2002 Sep; 58(Pt 9):1393-9. PubMed ID: 12198294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular basis of antifolate resistance.
    Assaraf YG
    Cancer Metastasis Rev; 2007 Mar; 26(1):153-81. PubMed ID: 17333344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of anti-filarial leads against aspartate semialdehyde dehydrogenase of Wolbachia endosymbiont of Brugia malayi: combined molecular docking and molecular dynamics approaches.
    Amala M; Rajamanikandan S; Prabhu D; Surekha K; Jeyakanthan J
    J Biomol Struct Dyn; 2019 Feb; 37(2):394-410. PubMed ID: 29334340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.